Total Payments
$1,144
2024 Payments
$150.36
Companies
15
Transactions
51
Medicare Patients
1,760
Medicare Billing
$153,476
Payment Breakdown by Category
Food & Beverage$1,144 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,144 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $362.64 | 13 | $0 (2024) |
| Lilly USA, LLC | $181.83 | 6 | $0 (2024) |
| ABBVIE INC. | $116.47 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $111.05 | 6 | $0 (2021) |
| Horizon Therapeutics plc | $78.24 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $73.00 | 5 | $0 (2023) |
| iRhythm Technologies, Inc. | $52.59 | 3 | $0 (2024) |
| Amgen Inc. | $30.14 | 2 | $0 (2024) |
| PFIZER INC. | $29.95 | 2 | $0 (2023) |
| Xeris Pharmaceuticals, Inc. | $23.98 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.36 | 8 | ABBVIE INC. ($43.00) |
| 2023 | $175.06 | 11 | ABBVIE INC. ($47.75) |
| 2022 | $520.84 | 19 | AstraZeneca Pharmaceuticals LP ($168.48) |
| 2021 | $269.80 | 11 | AstraZeneca Pharmaceuticals LP ($158.75) |
| 2018 | $11.80 | 1 | Lilly USA, LLC ($11.80) |
| 2017 | $16.33 | 1 | Genentech USA, Inc. ($16.33) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Gastroenterology | ||||||
| 02/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Obesity | ||||||
| 12/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Respiratory | ||||||
| 05/26/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/11/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: INSOMNIA | ||||||
| 12/13/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: Diabetes | ||||||
| 12/06/2022 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/16/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $35.70 | General |
| Category: Diabetes | ||||||
| 10/04/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Diabetes | ||||||
| 10/03/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 617 | 959 | $58,563 | $29,903 |
| 2022 | 15 | 479 | 658 | $51,854 | $27,475 |
| 2021 | 6 | 314 | 618 | $81,615 | $43,159 |
| 2020 | 8 | 350 | 715 | $124,750 | $52,939 |
Total Patients
1,760
Total Services
2,950
Medicare Billing
$153,476
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 151 | $15,450 | $9,033 | 58.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 89 | $13,090 | $6,580 | 50.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 27 | 63 | $5,985 | $3,476 | 58.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $2,600 | $1,550 | 59.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 41 | $3,275 | $1,429 | 43.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 53 | 75 | $3,005 | $1,235 | 41.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,880 | $1,152 | 40.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 56 | 79 | $2,217 | $1,036 | 46.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,800 | $911.29 | 32.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 59 | 84 | $2,357 | $869.40 | 36.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 59 | 92 | $1,477 | $700.12 | 47.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 54 | 72 | $1,589 | $685.44 | 43.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 61 | 109 | $658.00 | $643.44 | 97.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 13 | 14 | $369.00 | $206.92 | 56.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 13 | 14 | $355.00 | $201.74 | 56.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 19 | 20 | $200.00 | $113.20 | 56.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 15 | 16 | $256.00 | $81.28 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 128 | $12,925 | $7,995 | 61.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 103 | $10,815 | $5,607 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 37 | $5,365 | $3,432 | 64.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $5,105 | $1,760 | 34.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $2,600 | $1,619 | 62.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 30 | 38 | $2,850 | $1,443 | 50.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $2,600 | $1,358 | 52.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 22 | 22 | $2,210 | $1,169 | 52.9% |
About Dr. Gilbert Melson, D.O
Dr. Gilbert Melson, D.O is a Emergency Medicine healthcare provider based in Florence, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2015. The National Provider Identifier (NPI) number assigned to this provider is 1235512591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilbert Melson, D.O has received a total of $1,144 in payments from pharmaceutical and medical device companies, with $150.36 received in 2024. These payments were reported across 51 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,144).
As a Medicare-enrolled provider, Melson has provided services to 1,760 Medicare beneficiaries, totaling 2,950 services with total Medicare billing of $153,476. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Internal Medicine, Student in an Organized Health Care Education/Training Program
- Location Florence, AL
- Active Since 07/06/2015
- Last Updated 03/22/2022
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235512591
Products in Payments
- FARXIGA (Drug) $207.28
- MOUNJARO (Drug) $156.45
- BREZTRI (Drug) $155.36
- XARELTO (Drug) $111.05
- VRAYLAR (Drug) $90.75
- KRYSTEXXA (Biological) $78.24
- TRELEGY ELLIPTA (Drug) $73.00
- ZIO XT Patch (Device) $52.59
- ELIQUIS (Drug) $29.95
- DALVANCE (Drug) $25.72
- GVOKE HYPOPEN (Drug) $23.98
- CAPLYTA (Drug) $23.85
- Activase (Biological) $16.33
- XIFAXAN (Drug) $16.25
- Aimovig (Biological) $15.41
- Otezla (Drug) $14.73
- QUVIVIQ (Drug) $14.16
- MINIMED 770G (Device) $13.71
- ZEPBOUND (Drug) $13.58
- JARDIANCE (Drug) $11.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Florence
Brian Cruz, M.d, M.D
Emergency Medicine — Payments: $8,943
Emergency Medicine $8,943
Dr. Michele Scott, M.d, M.D
Emergency Medicine — Payments: $2,994
Emergency Medicine $2,994
Dr. William Cauthen, Md, MD
Emergency Medicine — Payments: $2,534
Emergency Medicine $2,534
Albert Smith, Md, MD
Emergency Medicine — Payments: $1,270
Emergency Medicine $1,270
Charles Albert, M.d, M.D
Emergency Medicine — Payments: $1,033
Emergency Medicine $1,033
Dr. Thomas Lewis
Emergency Medicine — Payments: $436.40
Emergency Medicine $436.40